Development of endometrial cancer after radiation treatment for cervical carcinoma

Obstetrics and Gynecology

Volumn 101, Issue 5, 2003, Pages 941-945

  Pothuri, Bhavana ^a   Ramondetta, Lois ^a   Martino, Martin ^a   Alektiar, Kaled ^a   Eifel, Patricia J ^a   Deavers, Michael T ^a   Venkatraman, Ennapadam ^a   Soslow, Robert A ^a   Barakat, Richard R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MUCINOUS CARCINOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME; UNDIFFERENTIATED CARCINOMA; UTERINE CERVIX CARCINOMA;

EID: 0038066162     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/s0029-7844(03)00234-5     Document Type: Article

References (14)

1. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-48.
2. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-43.
3. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53.
4. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-61.
5. Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-13.
6. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
7. Fehr PE, Prem KA. Malignancy of the uterine corpus following irradiation therapy for squamous cell carcinoma of the cervix. Am J Obstet Gynecol 1974;119:685-92.
8. Gallion HH, Van Nagell JR, Donaldson ES, Powell DE. Endometrial cancer following radiation therapy for cervical cancer. Gynecol Oncol 1987;27:76-83.
9. Rodriguez J, Hart WR. Endometrial cancer occurring 10 or more years after pelvic irradiation for carcinoma. Int J Gynecol Pathol 1982;1:135-44.
10. Curtin JP, Kavanagh JJ, Fox H, Spanos WJ Jr. Corpus: Mesenchymal tumors. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and practice of gynecologic oncology 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2000:961.
11. Prakash V, Carcangiu M. Uterine papillary serous carcinoma after radiation therapy for carcinoma of the cervix. Cancer 1992;69:496-501.
12. Barnhill D, Heller P, Dames J, Hoskins W, Gallup D, Park R. Persistence of endometrial activity after radiation therapy for cervical carcinoma. Obstet Gynecol 1985;66:805-8.
13. Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogen. N Engl J Med 1975;293:1167-70.
14. Jick SS. Combined estrogen and progesterone use in endometrial cancer. Epidemiology 1993;4:384.